A novel family of antitumor antibiotics, designated LL-D49194, was isolated from the fermentation broth of an actinomycete strain identified as Streptomyces vinaceus-drappus. LL-D49194 a1 and p2 were active against Gram-positive and inactive against Gram-negative bacteria in vitro. The p± component was not active against either Gram-positive or Gram-negative bacteria. These antibiotics exhibited significant in vivo activities against several murine tumors, albeit with differing potencies.
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In the course of our search for novel antitumor agents produced by microorganisms, a culture designated LL-D49194was isolated from a soil sample and was found to produce a new family of antitumor compounds( Fig. 1 ). This paper describes the taxonomy of the producing culture, fermentation and biological activities of these agents.
Materials and Methods

Microorganism
Culture LL-D49194 was isolated from a soil sample collected in La Encanada, Peru. This culture was Fig. 1 . Chemical structures of LL-D49194 al5 px and f}2. 254 THE JOURNAL OF ANTIBIOTICS MAR. 1990 deposited with the Northern Regional Research Center's Culture Collection Laboratory under the accession
No. NRRL 15735.
Taxonomic Studies
The taxonomic studies were carried out as described by the International Streptomyces Project (ISP)1* and Gordon et al.2) . For the evaluation of cultural characteristics, the strains were incubated for 14-31 days at 28°C. Cell wall composition was analyzed by the methods of Lechevalier and Lechevalier3).
Media and Fermentation
Culture LL-D49194 was stored as a frozen suspension at -70°C in growth medium. A 1.5-ml aliquot of thawed suspension was used to inoculate 100 ml of seed medium (yeast extract 0.5%, beef extract 0.3%, Tryptose 0.5%, glucose 1.0% and CaCO30.1%) in a 500-ml Erlenmeyer flask. This seed inoculum was incubated on a rotary shaker (5cm orbit) at 200rpm, 28°C, for 48 hours and was then added to a 3 liter fermenter containing 1 liter of seed medium. Following 48 hours incubation (aeration: 1 v/v/m, 450 rpm), the contents of this fermenter were inoculated into 30 liters of seed medium (molasses 2.0%, peptone 0.5%, glucose 1.0% and CaCO30.1%) in a 41-liter fermenter. This culture was grown at 32°C for up to 48 hours (aeration: 1 v/v/m, 350rpm). The contents from this fermenter were inoculated into a 410-liter fermenter containing 300 liters of seed medium (aeration: 0.75 v/v/m, 250 rpm). After 48 hours growth at 32°C, these 300 liters were used to inoculate a production fermenter containing 3,000 liters of medium (glucose 3.0%, molasses 1.0%, peptone 0.5% and CaCO30.1%). This fermentation was carried out at 28°C for up to 150 hours (aeration: 0.66v/v/m, 450rpm). The pH of the seed and production media used in these studies was adjusted to 6.8~7.0 prior to sterilization.
Microbial growth was determined by packed cell volume. Antibiotic production was monitored by the biochemical prophage induction assay (BIA)4'5) and analytical HPLC6).
Isolation and TLC/Bioautography
The BIAactive compoundsproduced by culture LL-D49194were associated with the myceliumand were recovered by extracting the whole fermentation broth with ethyl acetate6). Antimicrobial and BIA activities on the TLCplates were detected by bioautography.
Antibacterial Activity
The in vitro antibacterial activities of the LL-D49194antibiotics against a spectrum of Gram-positive and Gram-negative bacteria were determined by an agar dilution method employing Mueller-Hinton medium. The lowest concentration of antibiotic that inhibited growth of a bacterial strain after 18 hours of incubation at 35°C was recorded as the MIC.
Antitumor Activity
The antitumor activity of each component was determined in male BDFXmice against P388 leukemia and B16 melanoma. The P388 leukemia test was initiated by ip injection of 106 cells per mouse in 0.5 ml of dilute ascitic fluid. For B16 melanoma, a 1 g portion of tumor was homogenized in 10ml of balanced salt solution, and a 0.5-ml aliquot was implanted intraperitoneally into each mouse. The antibiotics were administered intraperitoneally days 1, 5 and 9 after initiation of the P388 test and by the same route on days 1 through 9 for B16. The antitumor activity was expressed as T/C values (median survival time of the treated group/median survival time of the untreated group x 100), with a value of > 125 being considered significant.
Results
Taxonomic Studies of the Producing Culture Culture LL-D49194 was isolated from a soil sample collected in La Encanada, Peru. Examination of the culture grown at 28°C for 14~31 days on various media revealed that spores were formed in coiled chains on aerial sporophores. The spores were ovoid (0.4~0.5 by 0.9~1.0^m), and the surface of the mature spores was smooth when observed by scanning electron microscopy. A summaryof the culture's growth characteristics on various media is presented in Tables 1~3. Wholecell analysis showed that the strain contained the L,L-isomer ofdiaminopimelic acid, placing it in the type I cell wall group of Lechevalier et al.7). Utilization of carbon sources is summarized in Table 4 . From the macromorphological, chemotaxonomic and physiological studies, it was concluded that culture LL-D49194 taxonomically resembles the reference strain of Strepnomyces vinaceus-drappus and is designated as a strain of this species.
Fermentation
Culture LL-D49194 was grown in a 3,000-liter fermenter at 28°C for 150 hours. A typical time course for the production of the antitumor antibiotic is shown in Fig. 2 . Antibiotic production started at approximately 24~30 hours after inoculation and reached maximumtiters at approximately 120 hours. Antibacterial Activity
The antibacterial activities of the al5 /?± and f$2 components of LL-D49194 are shown in Table 5 . The Antitumor Activity The antitumor activities of the al9^± and p2 componentswere determined in male BDFX mice against P388 leukemia and B16 melanoma. The results are summarizedin Table 6 . These agents exhibited activity against both tumors; however a1 and p2 were significantly more potent than film good utilization. Median survival time. 30 days for P388. 60 days for B16.
Discussion
A novel complex of antitumor antibiotics, designated LL-D49194, was isolated from the fermentation broth of an actinomycete, S. vinaceus-drappus. The a1 and /?2 components were active against Gram-positive bacteria and exerted antitumor effects against both P388 leukemia and B16 melanomain mice. The Pl component was inactive against the test bacteria; however, it did possess antitumor activity. Preliminary studies indicate that the antitumor effect of cc1 is related to its ability to bind to and damageDNA8).The LL-D49194 family of antitumor antibiotics are related structurally to but are distinct from the trioxacarcins produced by Streptomyces bottropensis9' 1 0\
